Saliva Collection and Diagnostics Market to Grow with a CAGR of 4.65% through 2029

Prevalence of Chronic and Infectious Diseases and Rising Demand for Non-Invasive Diagnostic Solutions are expected to drive the Global Saliva Collection and Diagnostics Market growth in the forecast period, 2025-2029

According to TechSci Research report, “Saliva Collection and Diagnostics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Saliva Collection and Diagnostics Market stood at USD 815.10 Million in 2023 and is anticipated to grow with a CAGR of 4.65% in the forecast period through 2029.

Saliva-based diagnostics are becoming indispensable in the realm of personalized medicine, offering a non-invasive means of collecting genetic and molecular data to support individualized treatment strategies. These diagnostics facilitate comprehensive genomic profiling, pharmacogenomics, and real-time monitoring of therapeutic responses, enabling healthcare providers to tailor interventions based on a patient’s unique biological makeup. This aligns seamlessly with the increasing emphasis on personalized healthcare, as medical practices shift towards precision treatments designed to optimize outcomes and minimize adverse effects.

The adoption of saliva diagnostics is further propelled by rising consumer awareness about the importance of preventive healthcare. With a growing understanding of the value of early disease detection, more individuals are turning to routine health screenings as a means of identifying potential health risks before symptoms emerge. Saliva-based tests, celebrated for their accessibility and ease of use, are ideally suited for such applications, bridging the gap between proactive health monitoring and user convenience. Their ability to seamlessly integrate into everyday health practices has made them a cornerstone of modern preventive medicine.

The shift towards at-home and point-of-care testing has also fueled the demand for saliva-based diagnostic kits. These solutions gained widespread recognition during the COVID-19 pandemic, offering consumers the ability to self-manage their health while reducing dependency on traditional healthcare facilities. As this trend continues, saliva-based kits are expected to remain highly sought after, empowering individuals with greater autonomy over their health and fostering a new era of decentralized diagnostics.

A favorable regulatory landscape is another critical factor driving the growth of saliva diagnostics. Regulatory authorities across the globe have increasingly approved saliva-based diagnostic tests, reinforcing their credibility and enabling their integration into mainstream clinical practice. These endorsements not only build market confidence but also encourage further innovation, paving the way for next-generation diagnostic tools that cater to evolving healthcare demands.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Saliva Collection and Diagnostics Market”

The Global Saliva Collection and Diagnostics Market is segmented into site of collection, application type, end user, regional distribution, and company.

Based on its site of collection, the Submandibular/sublingual Gland Collection segment has emerged as the predominant market leader, Saliva collected from the submandibular and sublingual glands is particularly valuable for diagnostic applications due to its rich composition of biomarkers, including proteins, enzymes, hormones, and nucleic acids. These glands produce mixed saliva that is dense in diagnostic components, making it ideal for detecting diseases such as cancer, cardiovascular conditions, and metabolic disorders. Submandibular/sublingual saliva is preferred for molecular diagnostics because it provides stable RNA and DNA suitable for genomic and epigenetic testing, critical for precision medicine. The proximity of these glands to the bloodstream allows the collection of saliva that reflects real-time physiological changes, enhancing the accuracy of diagnostics. The biomarker-rich nature of submandibular/sublingual saliva ensures its dominance in clinical diagnostics and research, positioning this segment as a leader in the market.

The submandibular/sublingual gland collection method is versatile, supporting a wide range of diagnostic applications from disease detection to therapeutic monitoring. Saliva from these glands is used for detecting infectious diseases like SARS-CoV-2, as well as chronic conditions such as diabetes and autoimmune disorders. It plays a critical role in the detection of oral, head and neck, and systemic cancers by enabling non-invasive liquid biopsies. Submandibular/sublingual saliva is increasingly used to monitor drug efficacy and metabolic changes in patients undergoing treatment, providing actionable insights in real time. The adaptability of this saliva collection method across diverse diagnostic needs enhances its market leadership, driving demand in both clinical and research settings. The non-invasive and straightforward nature of collecting saliva from the submandibular and sublingual glands has boosted its acceptance among patients and healthcare providers. Painless Collection: Saliva collection from these glands eliminates the discomfort associated with invasive sampling methods like blood draws. This method is particularly advantageous for children, elderly patients, and individuals with needle phobia, increasing compliance rates across demographic groups. The ease of submandibular/sublingual collection has made it integral to point-of-care and home-based diagnostic kits, which have gained significant traction globally. The high patient compliance associated with this collection method strengthens its market dominance, particularly in decentralized healthcare models.

The Asia Pacific region is poised to experience the fastest growth in the global saliva collection and diagnostics market. Asia Pacific is witnessing significant investments in healthcare infrastructure, enabling the adoption of advanced diagnostic technologies, including saliva-based diagnostics. Rising Government Investments: Countries like China, India, and Southeast Asian nations are prioritizing healthcare modernization, enhancing access to cutting-edge diagnostic tools. The proliferation of private hospitals and diagnostic labs is further facilitating the adoption of saliva-based diagnostics. Rapid urbanization is leading to improved healthcare facilities in cities, while governments are implementing programs to bring diagnostics to rural and underserved areas. The development of healthcare systems in Asia Pacific creates a fertile ground for the expansion of saliva diagnostics, particularly in regions with previously limited diagnostic capabilities.

Asia Pacific bears a high burden of chronic and infectious diseases, creating a strong demand for innovative and accessible diagnostic solutions. The rising incidence of diabetes, cardiovascular diseases, and cancer in the region has increased the need for non-invasive diagnostics that enable early detection and monitoring. High rates of infectious diseases such as tuberculosis, hepatitis, and influenza, coupled with the recent impact of COVID-19, have accelerated the demand for saliva-based testing due to its convenience and scalability. Governments and healthcare organizations in the region are promoting preventive health strategies, where saliva diagnostics play a critical role. The pressing need to address the dual challenge of chronic and infectious diseases positions saliva diagnostics as an essential tool for healthcare providers across Asia Pacific. As awareness of non-invasive diagnostics grows among consumers and healthcare professionals, saliva-based testing is becoming a preferred choice in the region. Non-invasive tests are gaining traction as they align with patient preferences for less discomfort and greater convenience. Increasing health literacy and awareness about early disease detection are driving demand for accessible diagnostic options like saliva tests. Employers in countries such as Japan, South Korea, and Singapore are adopting saliva-based diagnostics as part of corporate wellness programs. The alignment of saliva diagnostics with consumer and institutional preferences enhances market penetration in Asia Pacific.

Major companies operating in Global Saliva Collection and Diagnostics Market are:

• Thermo Fisher Scientific Inc.
• Neogen Corporation
• Abbott
• SARSTEDT AG & Co. KG
• AUTOGEN INC
• Oasis Diagnostics® Corporation
• Porex Technologies GmbH
• Salimetrics, LLC
• Takara Bio Inc.
• ARP American Research Products, Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The global saliva collection and diagnostics market is poised for transformative growth, driven by advancements in non-invasive technologies, increasing adoption of personalized medicine, and a growing focus on preventive healthcare. With its versatility, ease of use, and expanding clinical applications, saliva-based diagnostics are redefining the landscape of healthcare diagnostics. While challenges such as standardization and market competition persist, ongoing innovation and rising investments in research and development continue to strengthen the market’s foundation. As healthcare systems worldwide prioritize accessibility, precision, and early disease detection, the saliva diagnostics market is set to play a pivotal role in shaping the future of modern medicine.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Saliva Collection and Diagnostics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Site of Collection (Parotid Gland Collection, Submandibular/Sublingual Gland Collection, Others), By Application (Disease Diagnostics, Forensic Applications, Research), By End User (Dentistry, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes), By Region, & Competition, 2019-2029F”, has evaluated the future growth potential of Global Saliva Collection and Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Saliva Collection and Diagnostics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]